Mesenchyme is the loosely organized tissue found throughout developing embryos, made up of scattered, star-shaped cells embedded in a gel-like substance. It serves as a kind of biological raw material: the precursor tissue from which bones, cartilage, muscle, fat, blood vessels, and connective tissues eventually form. What makes mesenchyme unusual is that it does not come from a single embryonic source. All three primary cell layers of the embryo contribute mesenchymal cells, and those cells can switch back and forth between organized sheet-like arrangements and this looser, more mobile state multiple times during development.
Where Mesenchyme Comes From
Most people who encountered embryology in a classroom were taught that mesenchyme is simply “embryonic connective tissue,” a shorthand that practically every anatomy textbook uses. That label, while not exactly wrong, is misleading. A recent review in Cellular and Molecular Life Sciences called out this convention directly, noting that nearly all textbooks and online databases describe early mesenchyme as embryonic connective tissue, which understates what the tissue actually is and where it originates.1PubMed Central. Embryonic mesenchyme, mesenchymal tumors and mesenchymal stem cells: need for clarification of cell types and standardization of biomedical terminology
The confusion stems from the fact that mesenchyme is not confined to one embryonic germ layer. In vertebrate embryos, all three germ layers (ectoderm, mesoderm, and endoderm) produce both organized epithelial cells and loosely arranged mesenchymal cells. That means mesenchyme contains precursors for a huge range of different cell types, far more than the word “connective tissue” implies.1PubMed Central. Embryonic mesenchyme, mesenchymal tumors and mesenchymal stem cells: need for clarification of cell types and standardization of biomedical terminology The mesoderm does contribute the largest share of mesenchymal cells, particularly those that go on to form muscle, bone marrow, and the circulatory system. But contributions from the other two layers matter enormously, especially in the head and face.
Ectomesenchyme and the Neural Crest
Some of the most important mesenchymal cells in the body do not come from the mesoderm at all. They come from the neural crest, a population of cells that originates in the ectoderm, the outermost embryonic layer. These cells migrate away from the developing nervous system and take on mesenchymal characteristics, forming what is called ectomesenchyme. In the head, ectomesenchyme generates cartilage, bone, and connective tissue, producing much of the cranial skeleton.2PubMed Central. The emergence of ectomesenchymal
The developmental sequence for these cells involves three main steps: they migrate from the early brain region into the pharyngeal arches (the embryonic precursors of the jaw, ear, and throat structures), they multiply as ectomesenchyme within those arches, and they then differentiate into their final structural forms.3PubMed. Signaling pathways crucial for craniofacial development revealed by endothelin-A receptor-deficient mice This is why defects in neural crest cell migration or signaling often show up as craniofacial abnormalities. A surprisingly large share of the face and skull relies on ectoderm-derived mesenchyme rather than mesoderm-derived mesenchyme.
Ectomesenchyme is arguably the most unusual product of the neural crest. While neural crest cells elsewhere in the body give rise to neurons and glial cells, which is consistent with their ectodermal origin, cranial neural crest cells generate skeletal and connective tissue cell types that overlap with what mesoderm normally makes.4PubMed Central. Reassessing the embryonic origin and potential of craniofacial ectomesenchyme This blurring of boundaries between germ layers is one reason mesenchyme is hard to define neatly. The tissue is defined more by its cellular behavior and loose physical arrangement than by its ancestry.
How Cells Become Mesenchymal
Cells do not simply start out as mesenchyme and stay that way. One of the most important processes in developmental biology is the ability of cells to switch between an organized, tightly packed epithelial state and a loose, mobile mesenchymal state. This switch, called epithelial-to-mesenchymal transition, happens when cells lose the polarity and adhesion that hold epithelial sheets together, gaining instead the ability to move independently through surrounding tissue.5PubMed. Molecular mechanism involved in epithelial to mesenchymal transition
This transition is not a one-time event. During development, cells can flip between epithelial and mesenchymal states several times, depending on the signals they receive from their environment. A network of signaling molecules and gene regulators controls the process, amplifying the initial trigger signals into a full cellular transformation.6PubMed Central. Epithelial Mesenchymal Transition in Embryonic Development, Tissue Repair and Cancer: A Comprehensive Overview The reverse process, mesenchymal-to-epithelial transition, is equally critical. In the developing kidney, for example, mesenchymal cells must convert into epithelial cells to form the functional filtering units called nephrons. Research has shown that specific receptor signaling is required for this reverse transition, and when it fails, nephron formation stalls.7PubMed. Prokineticin receptor 1 is required for mesenchymal-epithelial transition in kidney development
Recent work in human kidney organoids has identified specific genes essential for initiating this reverse process. One study found that suppressing a particular gene called PAX8 led to roughly an 80% drop in a key cell-adhesion protein, effectively blocking the mesenchymal cells from organizing into epithelial structures.8Developmental Cell. Transcriptional mechanisms of human renal mesenchymal-to-epithelial transition Findings like these underscore how tightly regulated the mesenchymal-to-epithelial switch must be for organs to develop normally.
Mesenchyme in Organ Building
Mesenchyme does not just passively supply raw material for organs. It actively participates in shaping them through constant back-and-forth signaling with epithelial layers. Lung development provides one of the best-studied examples. The airways of the lung form through a process called branching morphogenesis, where a tube of epithelial cells repeatedly splits into smaller branches, like a tree growing new limbs. This branching depends on signaling between the epithelial lining and the surrounding mesenchyme.
Two major signaling families, Wnt and FGF, are crucial for this crosstalk. They coordinate the dynamic, reciprocal communication between the epithelial tubes and the mesenchyme that surrounds them.9PubMed Central. Wnt and FGF mediated epithelial-mesenchymal crosstalk during lung development When this signaling is disrupted in animal models, the results are dramatic. Experiments knocking out a regulatory protein called BRD4 in the lung epithelium led to impaired crosstalk with the mesenchyme, resulting in dilated airways and cystic expansion of the distal branching tips instead of normal fine branching.10bioRxiv. Endodermal BRD4 mediates epithelial-mesenchymal crosstalk during lung development
This pattern of epithelial-mesenchymal conversation is not unique to the lungs. Similar signaling dialogues drive the formation of kidneys, teeth, salivary glands, and many other branched or tubular organs. The mesenchyme in each location provides locally specific signals that tell the epithelial cells what to do, which is one reason the same general tissue type can participate in building such different organs depending on where in the body it sits.
The Physical Environment of Mesenchymal Cells
Mesenchymal cells do not float in empty space. They live within an extracellular matrix, a mesh of proteins and sugar-rich molecules that provides physical structure and biochemical signals. In the embryo, this matrix is rich in molecules like fibronectin, tenascin, and hyaluronic acid.11PubMed Central. Localisation of extracellular matrix components in the embryonic human notochord and axial mesenchyme The composition and stiffness of this matrix are not just background scaffolding; they actively influence how mesenchymal cells behave.
Research shows that matrix stiffness strongly affects how mesenchymal cells migrate. In gels mimicking tissue stiffness, cells adopt different movement strategies depending on how rigid their surroundings are. At lower stiffnesses, cells tend to squeeze through without breaking down the surrounding material, while in stiffer environments they switch to a mode that involves digesting the matrix ahead of them.12PubMed Central. Elucidating the role of matrix stiffness in 3D cell migration and remodeling The cells essentially read the mechanical properties of their environment and adjust their behavior accordingly, including how fast they move and in what direction. In one study, the fastest cell migration happened on the softest substrates, particularly when chemical attraction signals were also present.13Journal of Cell Science. Matrix elasticity regulates mesenchymal stem cell chemotaxis
This sensitivity to physical surroundings matters for understanding both normal development and disease. A stiffer-than-normal tissue environment, such as the fibrotic tissue found in scarring, can push mesenchymal cells to behave differently than they would in healthy, softer tissue.
Adult Mesenchymal Stem Cells
Mesenchyme is not purely an embryonic phenomenon. Adults retain populations of mesenchyme-related cells, most famously the mesenchymal stem cells (often called mesenchymal stromal cells, or MSCs) found in bone marrow, fat tissue, umbilical cord, and several other locations. These cells can give rise to bone-forming osteoblasts, cartilage-forming chondrocytes, and fat cells. In bone marrow, one well-characterized population expresses a receptor called LepR and sits around blood vessels, where it serves as a source of chemical signals that help maintain the bone marrow environment. These LepR-expressing cells have been shown to produce bone, cartilage, and fat tissue in living animals.14Cell Stem Cell. Mesenchyme: Its Origins, Function, and Significance
Beyond their ability to build structural tissues, adult MSCs also influence the immune system. They interact with immune cells both through direct contact and by releasing soluble molecules and tiny membrane-bound packets called extracellular vesicles, which can dampen inflammatory responses.15PubMed Central. Mesenchymal Stem/Stromal Cells and Their Paracrine Activity-Immunomodulation Mechanisms and How to Influence the Therapeutic Potential This immunomodulatory role has driven enormous interest in using MSCs as therapies, a topic that has generated both real progress and considerable frustration.
What Single-Cell Technology Has Revealed
For years, MSCs were treated as a fairly uniform population. That picture has changed dramatically with single-cell sequencing, which lets researchers read the gene activity of thousands of individual cells rather than averaging across an entire sample. Studies using this technology have revealed that what we call “MSCs” actually contain several distinct subpopulations, each with different characteristics.
One large-scale study sequenced over 61,000 MSCs from bone marrow and umbilical cord tissue, identifying five distinct subpopulations arranged along a developmental trajectory. At one end sat stem-like, rapidly dividing cells expressing markers associated with blood vessel walls. These cells branched into two paths: one leading toward fat-cell precursors, the other toward bone and cartilage precursors. One subpopulation destined for cartilage specifically expressed genes involved in immune regulation and could suppress the activity of immune T cells in laboratory experiments.16PubMed Central. Single-cell Transcriptomic Analysis Reveals the Cellular Heterogeneity of Mesenchymal Stem Cells
Similar work on bone marrow MSCs identified subpopulations corresponding to distinct differentiation trajectories toward bone, cartilage, and fat, along with a group of quiescent cells that seemed to be in a resting state.17PubMed Central. Single-cell RNA sequencing deconvolutes the in vivo heterogeneity of human bone marrow-derived mesenchymal stem cells This heterogeneity matters practically, because it helps explain why MSC-based therapies have produced inconsistent results. A batch of “MSCs” given to one patient may contain a very different mix of subpopulations than a batch given to another, making it hard to predict outcomes.
When Mesenchymal Programs Go Wrong
The same cellular flexibility that makes mesenchyme so useful in development can cause serious problems when it gets reactivated in adults under the wrong circumstances. Two major disease categories illustrate this: fibrosis and cancer.
In fibrosis, cells called myofibroblasts are the primary culprits. Myofibroblasts are essentially activated mesenchymal cells that produce excessive amounts of extracellular matrix proteins, leading to scarring that can progressively destroy organ function. In many fibrotic diseases, these cells originate from local mesenchyme-derived populations rather than arriving from distant sources.18PubMed Central. Fibroblast-Extracellular Matrix Interactions in Tissue Fibrosis Myofibroblast activation is a normal part of wound healing. The problem arises when these cells do not shut off. Brief activation helps repair damaged tissue, but persistent activation drives pathological scarring.19Nature Reviews Molecular Cell Biology. Mesenchyme: Its Origins, Function, and Significance In autoimmune conditions like systemic sclerosis, myofibroblasts are ultimately responsible for the fibrosis that threatens organ function and life.20Nature Reviews Rheumatology. Mechanisms and therapies for myofibroblast persistence in organ fibrosis
In cancer, the epithelial-to-mesenchymal transition that is so useful during embryonic development gets hijacked. Tumor cells can reactivate this program to gain the ability to detach from a primary tumor and migrate to new locations, a key step in metastasis. Mesenchymal stem cells themselves can also be co-opted by tumors. When MSCs were exposed to signals from ovarian cancer cells for 16 days in the laboratory, they transformed into tumor-associated fibroblasts, expressing a suite of markers associated with tumor support and progression that the original MSCs did not express.21PLOS ONE. Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression The tumor essentially recruits nearby mesenchymal cells and reprograms them to build a supportive microenvironment.
Mesenchymal Cell Therapies and Their Hurdles
The therapeutic potential of MSCs has driven hundreds of clinical trials across a wide range of conditions, from joint cartilage injuries and heart disease to graft-versus-host disease and autoimmune disorders. The safety record has been consistently good, with very few adverse events reported across trials. A handful of MSC-based products have even reached the market in some countries, including treatments for graft-versus-host disease and knee cartilage repair.22PubMed Central. Mesenchymal Stem Cell-Based Therapies: Challenges and Enhancement Strategies
Despite these milestones, MSC therapies remain limited in widespread clinical use. The landscape is, frankly, messy. Trials have used cells from different tissue sources (bone marrow, fat, umbilical cord), expanded them under different conditions, and applied them to a huge variety of diseases, making it difficult to compare results across studies.23PubMed. Challenges for mesenchymal stromal cell therapies The single-cell findings discussed earlier add another layer of explanation: if “MSCs” are actually a mix of functionally distinct subpopulations, then two batches of cells that look identical by standard quality checks could behave very differently once transplanted. Solving this will likely require better ways to identify and select for the specific subpopulations that drive the desired therapeutic effect, rather than treating all MSCs as interchangeable.
An Evolutionary Perspective on Mesenchyme
Mesenchyme-like cell behaviors are not limited to vertebrates. Looking across the animal kingdom, the ability of cells to adopt a loose, migratory arrangement appears to be extremely ancient. Even animals with only two body layers, like sea anemones, express genes that in vertebrates are associated with mesoderm and mesenchyme formation. These genes are active primarily in the inner cell layer of the anemone, supporting the idea that mesoderm, and by extension much of the mesenchyme in more complex animals, may have originally evolved from the inner body layer of a simpler ancestor.24PubMed. Investigating the origins of triploblasty: ‘mesodermal’ gene expression in a diploblastic animal, the sea anemone Nematostella vectensis
Planarians, the flatworms famous for their ability to regenerate entire body parts from small fragments, offer another window into mesenchyme-like biology. Their regenerative ability depends on a stem cell population called neoblasts, which includes pluripotent cells capable of producing any cell type in the body. Positional information guiding these stem cells is carried primarily by muscle cells, which are themselves of mesenchymal origin.25PubMed Central. The Cellular and Molecular Basis for Planarian Regeneration In these animals, the mesenchymal compartment is not just structural support; it serves as the body’s map, telling stem cells what to rebuild and where. This is a role that goes well beyond anything implied by calling mesenchyme “embryonic connective tissue,” and it hints at how central mesenchymal cell behaviors have been to animal body plans for hundreds of millions of years.
The Terminology Problem
One recurring challenge in this field is that the word “mesenchymal” gets attached to very different things. Embryonic mesenchyme, adult mesenchymal stem cells, mesenchymal tumors, and the epithelial-to-mesenchymal transition all use the same adjective but refer to different biological contexts. This overlap in terminology creates real confusion, both among researchers and in clinical settings. A tumor pathologist diagnosing a “mesenchymal tumor” is not necessarily thinking about the same biology as a stem cell researcher expanding “mesenchymal stem cells” for a clinical trial, even though both are using the same root word.
The review in Cellular and Molecular Life Sciences that flagged the textbook problem also called for better standardization of these terms, arguing that the loose usage creates genuine risks of miscommunication in both research and medicine.1PubMed Central. Embryonic mesenchyme, mesenchymal tumors and mesenchymal stem cells: need for clarification of cell types and standardization of biomedical terminology The fact that mesenchyme itself is defined by a cell’s physical arrangement and behavior rather than its lineage or location makes clean definitions harder. A cell that looks and acts mesenchymal today might have been epithelial yesterday and could become epithelial again tomorrow. This fluidity is precisely what makes mesenchyme biologically powerful, and precisely what makes it so difficult to pin down with a single tidy definition.